Hyserpin

   
Google
 
Web NewDrugInformation.com

Hyserpin


Drug - Hyserpin
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Rauwolfia Serpentina
Multiple ingredients are in alphabetical order.

Strength - 50MG
The potency of the active ingredient(s), Rauwolfia Serpentina. May repeat for multiple part products.

Applicant - PHYS PRODS VA
The firm name holding legal responsibility for Hyserpin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 010581
The FDA assigned number to Hyserpin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Hyserpin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Hyserpin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Hyserpin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Hyserpin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Physicians Products Co Inc Div International Latex Corp
The full name of the firm holding legal responsibility for the new application of Hyserpin.

Hyserpin